Who owns ASCENTAGE PHARMA GROUP INTL?

Tip: Access positions for across all investors

Analyze quarterly positions in Ascentage Pharma Group Intl with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Ascentage Pharma Group Intl stock

Who bought or sold ASCENTAGE PHARMA GROUP INTL this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Point72 18k $700k -14% Sep 2025
 View chart
Point72 Asset Management 17k $439k 100% Dec 2025
 View chart
XY Capital 14k $358k -25% Dec 2025
 View chart
Citadel Advisors 9.7k $383k 100% Sep 2025
 View chart
UBS Group 4.2k $111k -77% Dec 2025
 View chart
Mirae Asset Global Investments 2.5k $67k 3% Dec 2025
 View chart
Tower Research Capital 230.00 $6.0k -72% Dec 2025
 View chart
Advisor Group Holdings 220.00 $5.8k 0% Dec 2025
 View chart
Bell Investment Advisors 67.00 $1.8k 0% Dec 2025
 View chart
EverSource Wealth Advisors 24.00 $630.000000 -64% Dec 2025
 View chart

Who sold out of Ascentage Pharma Group Intl?

Fund or Company Name Date Sold Shares Held Valued At
Tema Etfs Sep 2025 10k $405k
NEOS Investment Management Sep 2025 10k $412k
Abc Arbitrage Sa Sep 2025 5.2k $204k